ArticleWorld journal of surgical oncology2021

Clinical impact of PD-L1 expression in triple-negative breast cancer patients with residual tumor burden after neoadjuvant chemotherapy.

Gizem Oner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.